However, partial or complete DPD deficiency is a well known pharmacogenetic syndrome, detected in 3% to 5% of the general population, which has been associated with severe and potentially lethal toxicity following 5-FU administration[11]. This evidence concerns the gene DPYD and hyperinsulinemic hypoglycemia, familial, 4.